WO2014013062A1 - Intelligent implanted health sensing device and assembly - Google Patents

Intelligent implanted health sensing device and assembly Download PDF

Info

Publication number
WO2014013062A1
WO2014013062A1 PCT/EP2013/065322 EP2013065322W WO2014013062A1 WO 2014013062 A1 WO2014013062 A1 WO 2014013062A1 EP 2013065322 W EP2013065322 W EP 2013065322W WO 2014013062 A1 WO2014013062 A1 WO 2014013062A1
Authority
WO
WIPO (PCT)
Prior art keywords
sensors
support structure
sensor
computer system
vessel
Prior art date
Application number
PCT/EP2013/065322
Other languages
French (fr)
Inventor
Nassir Navab
Amin Katouzian
Original Assignee
Nassir Navab
Amin Katouzian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nassir Navab, Amin Katouzian filed Critical Nassir Navab
Priority to US14/415,232 priority Critical patent/US20150164372A1/en
Priority to CN201380038579.4A priority patent/CN104703532A/en
Priority to EP13739235.3A priority patent/EP2941179A1/en
Publication of WO2014013062A1 publication Critical patent/WO2014013062A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/076Permanent implantations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • A61B5/02158Measuring pressure in heart or blood vessels by means inserted into the body provided with two or more sensor elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4851Prosthesis assessment or monitoring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6862Stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6876Blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/285Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR
    • G01R33/287Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR involving active visualization of interventional instruments, e.g. using active tracking RF coils or coils for intentionally creating magnetic field inhomogeneities
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0204Operational features of power management
    • A61B2560/0214Operational features of power management of power generation or supply
    • A61B2560/0219Operational features of power management of power generation or supply of externally powered implanted units

Definitions

  • Embodiments of the present invention relate to devices and methods for monitoring vascular health conditions, e.g. restenosis and/or thrombosis.
  • Embodiments of the present invention particularly relate to sensor arrangements in support structures configure for implantation, e.g. stents, and/or to communication techniques of sensor arrangements utilized in such support structures.
  • they relate to medical devices configured for monitoring one or more health conditions, particularly restenosis, and to methods of monitoring a health condition, particularly restenosis.
  • the word “atherosclerosis” comes from the Greek words “athero” and “sclerosis”, meaning gruel or paste and hardness, respectively.
  • atheromatous plaque consisting of fatty substances (i.e. cholesterol), platelets, cellular waste products, and calcium build up in the innermost layer of an artery called endothelium.
  • the disease is typically asymptomatic, chronic, slowly progressive, cumulative, and eventually leads to plaque ruptures and therefore clots inside the artery lumen cover the ruptures.
  • the clots heal and usually shrink but leave behind stenosis (narrowing) or in worst case scenario complete occlusion of the artery.
  • Atherosclerotic disease may occur anywhere throughout vascular system.
  • coronary heart disease CHD
  • CAD coronary atherosclerotic disease
  • the choice of physical treatment approach depends on severity of extended disease, which could lead to minimally invasive (e.g. angioplasty, stent implantation), or invasive (e .g. bypass, heart transplantation) surgical procedures.
  • Atherosclerosis could occur in peripheral arteries that supply blood from heart to head, arms, legs, kidneys and stomach.
  • AAA abdominal aortic aneurysm
  • AAA is the 13th leading cause of death in the US and about 15000 Americans die each year. It is also a chronic disease and when it ruptures only 10-25% of patients survive leaving 75-90% fatality.
  • CAD and peripheral atherosclerotic disease (PAD) the AAA is stabilized through stent implantation procedure too, known as endovascular aortic (aneurysm) repair (EVAR).
  • a device or assembly configured for monitoring one or more health conditions, particularly restenosis.
  • the device or assembly includes : two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided, e.g. implanted, in a vessel, wherein each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft, a support structure for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is closer to the distal end than another one of the two or more sensors.
  • a device or assembly configured for monitoring one or more health conditions, particularly restenosis.
  • the device includes one or more sensors configured to be implanted in a vascular, wherein the one or more sensors are configured to sense at least pressure values, a support structure for supporting the one or more sensors, and an a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values.
  • a device or assembly configured for monitoring one or more health conditions, particularly restenosis.
  • the device includes one or more electronic chips integrated with sensors configured to be implanted in a vascular, wherein the one or more electronic chips are configured to transmit one or more sensed indices wirelessly, e.g. at least pressure values, a support structure for supporting the one or more sensors and chips, and an a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values.
  • a method of monitoring a health condition, particularly restenosis includes: wirelessly energizing at least one sensor, which senses at least vascular pressure values, with a remote device, reading at least the pressure values for a predetermined time period via a wireless data transfer from the at least one sensor, communicating the pressure values to a computer system, and receiving information related to the health condition from the computer system.
  • a device or assembly configured for monitoring one or more health conditions, particularly restenosis.
  • the device or assembly includes: two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided, e.g.
  • each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft, a support structure having two or more rings configured to be implanted in a vessel and for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is arranged at a first ring of the two or more rings, which is closer to the distal end than a second ring of the two or more rings, wherein at least another sensor of the two or more sensors is attached to the second ring, and a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values and a reading device configured for wireless communication with the two or more sensors and comprising a port for wired or wireless communication with a computer system, wherein the computer system is a system selected from the group consisting of: a personal computer, a portable computer, a smartphone, a server, a cloud computer system, and combinations thereof.
  • Embodiments are also directed at apparatuses for carrying out the disclosed methods and include apparatus parts for performing each described method step. These method steps may be performed by way of hardware components, a computer programmed by appropriate software, by any combination of the two or in any other manner. Furthermore, embodiments according to the invention are also directed at methods by which the described apparatus operates. It includes method steps for carrying out every function of the apparatus.
  • FIGS. 1A to ID show medical devices including stents as support structures and sensors according to embodiments described herein;
  • FIG. 2 shows a medical device including a stent assembly as a support structure and sensors according to embodiments described herein;
  • FIGS. 3A to 3C illustrate the monitoring of restenosis with medical devices according to embodiments described herein and with methods according to embodiments described herein;
  • FIG. 4 illustrates a system including a stent, a sensor, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein;
  • FIGS. 5 and 6 illustrate yet further systems including support structures, at least one sensor, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein;
  • a health condition e.g. restenosis
  • FIGS. 7 A and 7B illustrate rings that can be used to form support structures for embodiments described herein;
  • FIGS. 8A to 8F illustrate sensors mounted to a ring for use in embodiments described herein;
  • FIG. 9 shows a medical device including a support structure and sensors according to embodiments described herein;
  • FIGS. 10A to IOC illustrate the monitoring of restenosis with medical devices according to embodiments described herein and with methods according to embodiments described herein;
  • FIG. 11 illustrate a flow chart for explain the benefits for treatment of e.g. restenosis and further deployment of angioplasty with medical devices according to embodiments described herein and with methods according to embodiments described herein;
  • FIGS. 12A and 12B illustrate systems including a support structure, sensors, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein; and
  • FIGS. 13A and 13B illustrate yet further systems including support structures, at least one sensor, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein.
  • a health condition e.g. restenosis
  • an intelligent implantable health sensing system can thereby, include one chip such as a RFID chip, or typically two or multiple RFID chips within support structure's length, e.g. stent's length, to measure and record spatially relative pressure differences.
  • the one or more RFID chips may be integrated with a sensor. Measuring pressure differences helps to monitor any abnormality (restenosis, hemorrhage) systematically for early detection of restenosis and/or failure of a stent. Further, development of disease- and patient-specific cardiac models for early detection of myocardial infarction can be based upon embodiments described herein.
  • At least one of the two or more sensors is mounted to the support structure adjacent to the distal end, and wherein the another one of the two or more sensors is mounted to the support structure adjacent to the proximal end.
  • the sensors can be employed as radiofrequency coils in magnetic resonance (MR) imaging systems.
  • the sensors and/or chips, which may be further integrated with further structures can be used as MRI coupling coils (passive coupling through a LC circuit tuned to the MRI lamor frequency) for intravascular imaging. This can provide imaging information about a stenosis grade and also about the structure of the plaque.
  • the health sensing system is supported with a user-interaction device, e.g.
  • the user-interaction device can be a computer or a mobile device, e.g. a smartphone and can optionally, be provided with back-end architecture for secure communication and recording of data and online/offline disease-, patient- , or patient-flow- modeling.
  • Embodiments described herein can provide a device in which senses the progression of restenosis and/or hemorrhage within the implanted stent upon user's request and sends this information to an external near-body device (e.g. a smartphone).
  • the data can, for example, then transferred to a centralized database for online processing and decision-making.
  • two or multiple chips (sensors) are designed along with a stent to collect pressure indices and/or temperature indices, flow rate indices, and/or possible biomarkers.
  • two (or multiple) pressure sensors are designed on stent or another support structure and the pressure indices will be fetched through an external near-body device, such as a remote device including a reading device.
  • the data is transferred to a centralized data station for online analysis and eventually a report is created. In case of life threatening situation, an alarm can be sent to an expert.
  • At least two adjacent to at proximal and distal points of a stent are provided, which are configured to monitor the relative pressures difference between the two sensors.
  • Multiple chips can also be designed within a stent another or support structure and therefore spatially relative pressures will be measured and recorded for any abnormality identification.
  • the devices and systems employ multiple sensors and measure the spatially relative pressure differences. Accordingly, variations in blood pressure due to stress or other abnormal health conditions can be compensated as the pressure difference at two predetermined positions, e.g. a proximal and distal end of a stent or a graft, is measured. Hence, embodiments facilitate detection of any abnormality within the stent in a simpler and more reliable manner compared to measurements with one sensor. Furthermore, in case one of the sensing devices would be malfunctioning due to a failure or due to extensive plaque covers on one of the sensing devices (chips), the other(s) sensing devices can continue providing information.
  • the devices and systems employ multiple sensors and/or chips and measure the spatially relative pressure differences.
  • the first measurements right after implantation can be deploy for data calibration.
  • the data calibration includes measured relative pressure differences, which are served to assess disease severity under different psychological and physical conditions (e.g. rest, exercise, stress, etc.). For example, saturation of sensors can be an indicative for abrupt or gradual changes in disease severity.
  • FIG. 1A illustrates a first embodiment of a medical device (100).
  • FIG. 1A shows two sensors 110 mounted in vicinity of opposing ends of a support structure, e.g. a stent 20.
  • the stent with the sensors attached thereto can be implanted in a blood vessel according to general usage of a stent for vascular disease.
  • the sensors 110 are provided in longitudinal direction of a blood vessel and can, thus, be configured to provide a pressure value at a first longitudinal position and a second longitudinal position. According to embodiments described herein, the pressure difference can be sensed to monitor the health condition as described in more detail with respect to FIGS. 3 A to 3C.
  • the sensors 110 can be radio-frequency chips or integrated with radio- frequency chips, similar to RFID chips. Thereby, the sensors are powered by an external RF source, e.g. in the GHz range, such as 2 GHz to 100 GHz. On receiving energy by the external source, the sensors 110 provide pressure values of the actual pressure at the sensor. The pressure values are transmitted with a wireless connection to an external reading device.
  • the external RF source and the reading device can be integrated in one remote device for powering and reading the sensors.
  • Such a remote device or the respective RF source and the reading device can be held next the patient's body part, in which the stent 20 with the sensor 110 is implanted for a predetermined period of time.
  • the pressure values can e.g. be read during a time period ranging from 5 seconds to 5 minutes, e.g. 2 min. A few heart cycles can be measured in that time period.
  • statistically improved pressure values e.g. average values or values optimized by other statistic models (e.g. variance correlation) and signal processing technique (e.g. spectral analysis) can be obtained.
  • the limitation to a predetermined time period further has the benefit that possible heat generation due to energy consumption of the chip can be limited to a time span, which is harmless to the tissue of the blood vessel in which the stent is implanted.
  • two sensors can be provided adjacent to the ends of the support structure, e.g. stent 20.
  • more than two sensors 110 can be provided.
  • FIG. IB for example four sensors 110 can be provided.
  • any other suitable number of sensors 110 can be provided, wherein the number may depend on the longitudinal length of the stent 20.
  • the data transmitted from the sensors to the reading device can consist of the pressure values as a function of time, yet, more information may be included as described in more detail below.
  • FIG. 1C and ID show corresponding embodiments of medical devices 100, where the sensors 110 are provide at the inside of the stent.
  • This arrangement is, for example, used when a membrane is used with the stent or a graft having a membrane is used as a support structure.
  • the blood pressure within the vasculature i.e. for example not in the sac of an aneurysm, is measured by the sensors 110 towards the inside side of the membrane.
  • the support structure which is configured to be implanted in a human or animal body together with the sensors 110, can be provided by a stent or a graft.
  • the support structure can also be provided by a stent arrangement comprising two or more stents.
  • FIG. 2 shows an example of a medical device with a support structure including three stents 20. Thereby, three stents 20 are shown as implanted in a blood vessel along a longitudinal direction of the vessel 10.
  • the medical device includes two sensors 110, which are arranged adjacent a distal and proximal end of the stent arrangement.
  • the sensors can have any predetermined longitudinal position along the support structure, e.g. the stent assembly, which provides a sufficient distance between a first sensor and a second sensor to sense a pressure difference indicative of the health condition to be monitored.
  • the predetermined position is defined merely by a longitudinal position, i.e. a rotation along the longitudinal axis is not considered and measurement results are irrespective thereof. This can, for example, be provided by the fact that pressure differences are considered.
  • FIGS. 3A to 3C show a medical device 100 provided in a blood vessel 10, wherein restenosis indicated by areas 30A, 30B and 30C increasingly occurs from 30A to 30B and further to 30C.
  • FIG. 3A shows a healthy condition or a condition which is almost healthy when considering a stent implantation.
  • FIG. 3B shows a growing restenosis.
  • FIG. 3C shows a critical restenosis.
  • the growing restenosis results in a reduced pressure value at the respective sensor 110 of the medical device 100.
  • a pressure difference between the sensor values corresponding to a time t is determined and the health condition, e.g..
  • the pressure difference indicated by arrow 320 the pressure difference can be considered at 60% to 90 %, e.g. 80% of the peak value (100%), either of the lower pressure peak as shown in the figures or of the higher pressure peak.
  • the pressure functions shown in the graphs of FIGS. 3A to 3C basically correspond to the pressure values during one heartbeat.
  • a measurement with a remote reading device is typically conducted for a longer time interval, e.g. 10 sec to 3 min, such that a more accurate measurement can be conducted as described above.
  • the data rate transmitted from a sensor to the remote device can range from 20 to 100 Kbit per second, for example 40-50 Kbit/s.
  • the restenosis can be detected within the support structure, e.g. a stent and/or between the at least two sensors.
  • FIG. 4 illustrates yet further embodiments described herein.
  • a medical device for implantation 400 includes a support structure, e.g. a stent, a stent arrangement, a graft, or the like, and at least on sensor 10 mounted to the support structure.
  • the sensors according to embodiments described herein typically have not internal power supply.
  • the sensor 1 10 is configured to sense at least the pressure inside a vascular.
  • further biological indices of interest can be included like one or more of a temperature, a flow rate or detection of biomarkers can be conducted as well. Thereby, for those embodiments having two or more corresponding sensors, value differences are considered at least for the pressure, the temperature and or the flow rate.
  • the senor can be provided by a MEMS (micro-electro-mechanical system).
  • a chip can be provided with a pressure sensor, a wireless power supply (see, e.g. RFID), a microelectronics and an antenna for transmitting the pressure values and/or further parameter values, or even a sensor ID to an external receiver or reading device.
  • the sensor can include an HF frontend module for transmitting the sensed values as a function of time.
  • the entire electronic can be provided on the chip.
  • the sensor or chip further includes the measurement device or mechanical device, e.g. the pressure gauge, a wireless power supply, wherein the energy is transmitted by RF radiation, e.g. in the GHz range to the sensor, and optionally also a control unit and/or evaluation unit.
  • a control unit and/or evaluation unit can also be provided in a remote reading device receiving the data.
  • RF radiation 415 is emitted by a remote device 410.
  • the RF radiation is used to energize the sensor 110, which in turn transmits data of measurement values and optionally other information as a wireless signal to the remote device 410 as indicated by signal 416.
  • the remote device 410 includes the transmitter for the RF energy as well as a reading device for reading the data transmitted from the sensor 110. Alternatively, the remote RF transmitted and the reading device can also be separated.
  • the remote device 410 is connected to a computer system 420 via connection 411.
  • the computer system can be a personal computer, a portable computer, a server structure, a cloud structure or combinations thereof. Typically, utilizing a back-end portal structure with encrypted communication techniques allows for further data processing.
  • FIG. 5 shows an embodiment where a medical device 100 having two sensors 110 is provided in a blood vessel 10.
  • the details for power supply and data transfer from the remote device 410 to the sensors 110 which have been described above with respect to FIG. 4 can also be incorporated in the embodiments described with respect to FIG. 5 to yield yet further embodiments.
  • the remote device 410 is connected to a computer system 420, e.g. a laptop, which is connected to the World Wide Web and server structure, e.g. in the form of a cloud solution 422. As indicated by the arrows in FIG. 5, the server structure can communicate back to the user.
  • the cloud solution facilitates sharing of information, e.g. with a medical expert.
  • FIG. 6 illustrates yet a further embodiment, where the remote device having the RF transmitter for energy transfer and the reading device for data receipt incorporated in a mobile device, such as a smart phone or the like, which can directly communicate with servers provided in a network.
  • a mobile device such as a smart phone or the like
  • Modifications and implementations described above with respect to sensor arrangement, measurement methods and sensor chip design and wireless communication techniques can likewise be applied for solutions shown in FIGS. 5 and 6.
  • a support structure which is configured to be implanted in a human or animal body together with the sensors 110, is provided.
  • the support structure can have two or more elements.
  • the sensors can be provided on different ones of the two or more elements.
  • the support structure can include: a stent, a stent arrangement, a graft, a graft arrangement, two or more rings, or two or more plates, e.g. plate patches, or other elements or medical devices that can be inserted in a vessel.
  • a ring can be provided as a short stent, i.e. a stent with a length in axial direction of 5 mm or below.
  • the rings are not employed or configured to push away plaques toward arterial walls and open up the site of occlusion but employed through balloon angioplasty by placing them at distal or proximal ends of an inflating balloon.
  • the primary role of the rings is to facilitate online monitoring of disease progression through presented embodiments.
  • the rings and support structures can according to some embodiments, which can be combined with other embodiments described herein, be self- expandable. According to typical embodiments, which can be combined with other embodiments described herein, the ring can be round, oval or any other shape configured to be arranged in a vessel of an animal or human.
  • the sensors can have any predetermined longitudinal position along the support structure, e.g. the stent arrangement or ring arrangement, which provides a sufficient distance between a first sensor and a second sensor to sense a pressure difference indicative of the health condition to be monitored.
  • the predetermined position is defined merely by a longitudinal position, i.e. a rotation along the longitudinal axis is not considered and measurement results are irrespective thereof. This can, for example, be provided by the fact that pressure differences are considered.
  • FIGS. 7A and 7B show pictures of rings 700A and 700B respectively.
  • the rings 700A and 700B have a similar structure as a stent. However they are comparably short in axial direction. According to one definition, a ring could have a dimension in axial direction, which is shorted than the diameter of the ring.
  • FIGS. 8A to 8F show different variations of providing sensors 110 provided at a ring 820.
  • FIGS. 8A to 8C show embodiments, for which one sensor 110 is attached or mounted to the ring 820. Thereby, according to different embodiments, the sensor can be provided to be essentially radially outward of the ring 820 (see FIG.
  • the ring can be closed by the sensor, i.e. the ring is attached on two sides of the sensors (see FIG. 8B).
  • the sensor has essentially the same radial position as the ring.
  • two sensors 110 can be provided on one ring 820. Similar to the description with respect to FIGS. 8A to 8C, the sensors 110 can be provide at different radial positions with respect to the ring. That is, the sensors 110 can be provided essentially radially outward (see FIG. 8D), essentially radially inward (see FIG. 8F, or essentially at a similar radial position as the ring (see FIG. 8E). It is to be understood that for two or more sensors, also different positions with respect to the ring 820 can be provided for one ring, i.e. one sensor is essentially radially inward and one sensor is essentially radially outward, etc.
  • 3 or 5 sensors can be provided at one ring.
  • Providing two or more sensors at the ring can increase the measurement accuracy because more than one signal can be obtained at one axial position, i.e. the axial position of the ring having the two or more sensors.
  • redundancy is provided in the event one of the two or more sensors fails to provide reliable signals, e.g. because of a failure or by coverage of plaque.
  • the other(s) sensing devices can continue providing information.
  • two rings 820 each with at least one sensor 110, forms a medical device 1200, as e.g. shown in FIG. 9.
  • the support structure of the medical device can be provided by two or more rings.
  • the two rings 820, wherein each ring 820 has two sensors 110 or sensing devices mounted thereon are configured to be implanted in a blood vessel along a longitudinal direction or axis 110 of the vessel 10. It is to be understood that even though the axis 110 is shown as a straight line in FIG. 9, the axis 110 is defined as following a potential curvature of the vessel 10.
  • the two rings 820 each having at least one sensor 110 form the medical device 1200 according to embodiments described herein.
  • the rings can be provide at predetermined positions along the axis 11 or at a predetermined distance along the axis 11 in order to be able to monitor the health condition with respect to plaque coverage of vessel 10.
  • FIGS. 10A to IOC show a medical device 1200 provided in a blood vessel 10, wherein stenosis or restenosis indicated by areas 30A, 30B and 30C increasingly occurs from 30A to 30B and further to 30C.
  • FIG. 10A shows a healthy condition or a condition which is almost healthy when considering a surgery.
  • FIG. 10B shows a growing restenosis.
  • FIG. IOC shows a critical restenosis.
  • the pressure levels 510, 520A, 520B and 520C the growing restenosis results in a reduced pressure value at the respective sensor of the medical device 1200.
  • a pressure difference between the sensor values is determined and the health condition, e.g.
  • the pressure difference indicated by arrow 550 the pressure difference can be considered to have a threshold at 50% to 90 %, e.g. 80% of the higher pressure. Accordingly, if the pressure difference exceeds a certain value or if the lower value 520A,B,C drops below a certain percentage of the higher value 510, a critical conditions is detected.
  • the restenosis can be detected within the support structure, e.g. a stent and/or between the at least two sensors. Alternatively, it is possible to use the plurality of pressure values also to sense restenosis or similar abnormality before or after the stent in the vicinity thereof.
  • FIG. 11 shows a flow chart illustrating the benefits in treatment of atherosclerotic disease, stenotic disease, other vascular disease, e.g. stenosis or restenosis, with and according to embodiments described herein, particularly when two or more rings 820 as shown in FIGS. 7A to IOC and 12A to 13B are utilized.
  • a stent implantation see box 116
  • This decision is indicated by dashed arrows 113 A.
  • the stent pushed away the plaque in the vessel to increase the open diameter of the vessel.
  • double stenting as indicated by arrow 113B could be used in some cases.
  • a medical device can be implanted in order to monitor the status of atherosclerosis , stenotic disease, other vascular disease, e.g. stenosis or restenosis, and improve the diagnosis.
  • a balloon angioplasty (see box 114) can be provided.
  • a balloon pushes away the plaque in a vessel.
  • each with at least one pressure sensor can be implanted.
  • atherosclerosis or other stenotic or vascular disease can be treated and at the same time a valuable monitor ability can be provided.
  • a stent implantation can be postponed, whereby the risk during postponing the stent implantation can be determined by the monitoring capability of the medical devices according to some embodiments described herein.
  • Such a surgery could be repeated, e.g. after one or two years as indicated by arrow 115.
  • a stent implantation (box 116) could be postponed with a good risk management. Thereby, several years (e.g. 1 to 3) can be gained before a stent implantation and consequently also before bypass surgery (see box 118) as a further step after stent implantation.
  • a monitoring capability can be provided by embodiments described herein. This is indicated by arrows 117 and 119. It is to be understood that the monitoring can be added in the same surgery as the stent implantation or the bypass surgery even though arrows 117 and 119 point back to the balloon angioplasty.
  • FIGS. 12A and 12B illustrate yet further embodiments described herein.
  • a medical device for implantation 1200 includes a support structure, which can be provided by two rings 820 in the form of a short stents or two other rings.
  • At least two sensors 110 are mounted to the support structure, wherein an axial distance is provided for the two sensors.
  • the sensors according to embodiments described herein typically have not internal power supply.
  • the sensors 110 are configured to sense at least the pressure inside a vascular.
  • one or more of a temperature, a flow rate or detection of biomarkers can be conducted as well. Thereby, for those embodiments having two or more corresponding sensors, value differences are considered at least for the pressure, the temperature and/or the flow rate.
  • the sensors can be provided by a MEMS (micro-electro-mechanical system).
  • a chip can be provided with a pressure sensor, a wireless power supply (see, e.g. RFID), a microelectronics and an antenna for transmitting the pressure values and/or further parameter values, or even a sensor ID to an external receiver or reading device.
  • the sensor can include an HF frontend module for transmitting the sensed values as a function of time.
  • the entire electronic can be provided on the chip.
  • the sensor or chip further includes the measurement device or mechanical device, e.g. the pressure gauge, a wireless power supply, wherein the energy is transmitted by RF radiation, e.g. in the GHz range to the sensor, and optionally also a control unit and/or evaluation unit.
  • a control unit and/or evaluation unit can also be provided in a remote reading device receiving the data.
  • RF radiation 415 is emitted by a remote device 410.
  • the RF radiation is used to energize the sensors 110, which in turn transmit data of measurement values and optionally other information as a wireless signal to the remote device 410 as indicated by signals 416.
  • the remote device 410 includes the transmitter for the RF energy as well as a reading device for reading the data transmitted from the sensors 110. Alternatively, the remote RF transmitted and the reading device can also be separated.
  • the remote device 410 is connected to a computer system 420 via connection 411.
  • the computer system can be a personal computer, a portable computer, a server structure, a cloud structure or combinations thereof. Typically, utilizing a back-end portal structure with encrypted communication techniques allows for further data processing.
  • FIG. 13A shows an embodiment where a medical device 1200 having two sensor 110 is provided in a blood vessel 10.
  • the support structure of the medical device can include two short stents or two rings.
  • the details for power supply and data transfer from the remote device 410 to the sensors 110, which have been described above with respect to FIGS. 12A and 12B can also be incorporated in the embodiments described with respect to FIG. 13A to yield yet further embodiments.
  • the remote device 410 is connected to a computer system 420, e.g. a laptop, which is connected to the World Wide Web and/or a server structure, e.g. in the form of a cloud solution 422.
  • the server structure can communicate back to the user.
  • the cloud solution facilitates sharing of information, e.g. with a medical expert.
  • FIG. 13B illustrates yet a further embodiment, where the remote device having the RF transmitter for energy transfer and the reading device for data receipt incorporated in a mobile device, such as a smart phone or the like, which can directly communicate with servers provided in a network.
  • a mobile device such as a smart phone or the like
  • servers provided in a network.
  • embodiments described herein serve for health monitoring of atherosclerotic disease, stenotic disease, other vascular disease, e.g. stenosis or restenosis after stent implantation, stent breakage, or the like.
  • Embodiments described herein can yield yet further embodiments, when utilized as methods where a continuous monitoring is provided.
  • remote device can be placed external to a human or animal body in the vicinity of or directed towards the implanted sensor(s) on a regular basis, e.g. daily or weekly or the like and the data can be transferred and evaluated accordingly. Thereby, growing restenosis can be sensed at an early stage.
  • the sensor or sensors provided use RF energizing techniques such as or similar to RFID chips.
  • the implanted sensor or sensors can be miniaturized sufficiently to also be provided in cardiovascular vessels, where stent length of 1.0 mm to 20 mm or other places at the human or animal body where stent length of 2 cm to 20 cm are utilized.
  • the implanted sensor or sensors can be miniaturized sufficiently to also be provided in vessels, where stent diameters are from 0.5 mm to 20 mm, e.g. from 1 mm to 15 mm, such as from 1 mm to 10 mm . Accordingly, the sensor can be miniaturized to a degree beyond previously known sensor for implantation.
  • two or more sensors are provided, wherein a pressure difference of at least two sensors is sensed. This simplifies and improves sensing of the health condition. Further, rotational positioning can be disregarded.
  • the support structure can be the stent or two or more stents, which are implanted for curing the vascular or cardiovascular disease. Accordingly, the health monitoring device is in place at least after the surgery for treating the original disease. Thereby, according to optional modifications, a calibration of the freshly implanted stent, e.g. an initial pressure difference can be provided.
  • the senor can be provided in a chip, e.g. as MEMS and/or as silicon based integrated HF circuits and particularly, with wireless broadband communication.
  • the sensor can be a SoC (System on Chip), wherein sterile packaging can be provided as known in the art.
  • SoC System on Chip
  • Data transmission from the sensor occurs initially to a remote device, e.g. a smart phone or another device, and is typically provided to a backend server portal, e.g. in the form of a server cloud solution.
  • the server solution can allow, e.g. with encrypted communication such as AES, reference to a plurality of sensor information, historical data, medication information, expert information from a doctor and other information of interest for a user. The information can be graphically shown to the user for ease of understanding.
  • a cloud solution allows access from different location and also access of different persons, e.g. doctors or emergency physicians.
  • a sensing system for quasi-continuous sensing as described herein and methods of monitoring can further include a test phase with a medication model A, where a plurality of measurement cycles are conducted for a time period of days or weeks and a test phase with a medication model B, where another plurality of measurement cycles are conducted for a period of days or weeks, such that an individual medication for each patient can be developed efficiently.

Abstract

A medical device configured for monitoring one or more health conditions, particularly restenosis, as described. The medical device includes two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided in a vessel, wherein each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft; and a support structure for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is closer to the distal end than another one of the two or more sensors.

Description

INTELLIGENT IMPLANTED HEALTH SENSING DEVICE AND ASSEMBLY
TECHNICAL FIELD OF THE INVENTION
[0001] Embodiments of the present invention relate to devices and methods for monitoring vascular health conditions, e.g. restenosis and/or thrombosis. Embodiments of the present invention particularly relate to sensor arrangements in support structures configure for implantation, e.g. stents, and/or to communication techniques of sensor arrangements utilized in such support structures. Specifically, they relate to medical devices configured for monitoring one or more health conditions, particularly restenosis, and to methods of monitoring a health condition, particularly restenosis.
BACKGROUND OF THE INVENTION
[0002] The word "atherosclerosis" comes from the Greek words "athero" and "sclerosis", meaning gruel or paste and hardness, respectively. As it is inferred from the name, it is a disease in which atheromatous plaque, consisting of fatty substances (i.e. cholesterol), platelets, cellular waste products, and calcium build up in the innermost layer of an artery called endothelium. The disease is typically asymptomatic, chronic, slowly progressive, cumulative, and eventually leads to plaque ruptures and therefore clots inside the artery lumen cover the ruptures. The clots heal and usually shrink but leave behind stenosis (narrowing) or in worst case scenario complete occlusion of the artery. [0003] Atherosclerotic disease may occur anywhere throughout vascular system. For example, coronary heart disease (CHD) that is the most common type of heart disease takes about 500,000 lives in the United States every year. In practice, coronary atherosclerotic disease (CAD) is treated by interventional radiologists or cardiologists through medication, non-invasive, or invasive procedures. The choice of physical treatment approach depends on severity of extended disease, which could lead to minimally invasive (e.g. angioplasty, stent implantation), or invasive (e .g. bypass, heart transplantation) surgical procedures. [0004] Atherosclerosis could occur in peripheral arteries that supply blood from heart to head, arms, legs, kidneys and stomach. Similar to CAD, a minimal invasive procedure could be performed to open up the blockage through angioplasty or stent implantation. Another disease that is also correlated with atherosclerosis is abdominal aortic aneurysm (AAA) that is enlargement of abdominal aorta for more than 50% of its original diameter. AAA is the 13th leading cause of death in the US and about 15000 Americans die each year. It is also a chronic disease and when it ruptures only 10-25% of patients survive leaving 75-90% fatality. Likewise CAD and peripheral atherosclerotic disease (PAD), the AAA is stabilized through stent implantation procedure too, known as endovascular aortic (aneurysm) repair (EVAR). [0005] For many years, the ultimate goal of an interventional cardiologist was to physically expand narrowed artery, using balloon and stent, or create additional blood supply connections through bypass surgery. With refinement of new intravascular imaging modalities, today, primary responsibility of an interventional cardiologist is not only to open up the site of occlusion but also to properly cure the atherosclerosis. For example, the United States food and drug administration (FDA) safety panel has suggested that cardiologists take more measures to reduce risks associated with the stents due to troubling headlines about potentially deadly clotting risks in small percentage of them. So far, researchers have mainly focused on the stents themselves and how they are made. But now, attention is turning more toward the way they are being used. There has been a consensus that widespread use of drug - coated stents may increase the risk of deadly clots formation, which has called attentions in the United States and widely reported in the media (Fox News report, October 9, 2008 - The New York Times, February 13 , 2007 - The Wall Street Journal, May 7, 2007 - The Boston Globe, December 26, 2004) and in many scientific journals. The medicine on the stent is released gradually over time to stop the progression of the scar tissue. However, the artery can become narrow again, which is known as restenosis. Currently, there is no systematic approach to monitor the progression of atherosclerosis or any abnormality like thrombosis within implanted stent and early detection of restenosis or possible myocardial infarction.
[0006] In view of the above, it is an object of the present invention to provide a devices and methods for monitoring restenosis and/or thrombosis and related disease that overcome at least some of the problems in the art. SUMMARY OF THE INVENTION
[0007] In light of the above, a device according to independent claims 1 and 3, and a method according to independent claim 11 are provided. Further aspects, advantages, and features of the present invention are apparent from the dependent claims, the description, and the accompanying drawings.
[0008] According to one embodiment a device or assembly configured for monitoring one or more health conditions, particularly restenosis, is provided. The device or assembly includes : two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided, e.g. implanted, in a vessel, wherein each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft, a support structure for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is closer to the distal end than another one of the two or more sensors.
[0009] According to another embodiment, a device or assembly configured for monitoring one or more health conditions, particularly restenosis, is provided. The device includes one or more sensors configured to be implanted in a vascular, wherein the one or more sensors are configured to sense at least pressure values, a support structure for supporting the one or more sensors, and an a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values. [0010] According to another embodiment, a device or assembly configured for monitoring one or more health conditions, particularly restenosis, is provided. The device includes one or more electronic chips integrated with sensors configured to be implanted in a vascular, wherein the one or more electronic chips are configured to transmit one or more sensed indices wirelessly, e.g. at least pressure values, a support structure for supporting the one or more sensors and chips, and an a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values.
[0011] According to a further embodiment, a method of monitoring a health condition, particularly restenosis, is provided. The method includes: wirelessly energizing at least one sensor, which senses at least vascular pressure values, with a remote device, reading at least the pressure values for a predetermined time period via a wireless data transfer from the at least one sensor, communicating the pressure values to a computer system, and receiving information related to the health condition from the computer system.
[0012] According to one embodiment a device or assembly configured for monitoring one or more health conditions, particularly restenosis, is provided. The device or assembly includes: two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided, e.g. implanted, in a vessel, wherein each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft, a support structure having two or more rings configured to be implanted in a vessel and for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is arranged at a first ring of the two or more rings, which is closer to the distal end than a second ring of the two or more rings, wherein at least another sensor of the two or more sensors is attached to the second ring, and a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values and a reading device configured for wireless communication with the two or more sensors and comprising a port for wired or wireless communication with a computer system, wherein the computer system is a system selected from the group consisting of: a personal computer, a portable computer, a smartphone, a server, a cloud computer system, and combinations thereof.
[0013] Embodiments are also directed at apparatuses for carrying out the disclosed methods and include apparatus parts for performing each described method step. These method steps may be performed by way of hardware components, a computer programmed by appropriate software, by any combination of the two or in any other manner. Furthermore, embodiments according to the invention are also directed at methods by which the described apparatus operates. It includes method steps for carrying out every function of the apparatus.
BRIEF DESCRIPTION OF THE DRAWINGS
[0014] So that the manner in which the above recited features of the present invention can be understood in detail, a more particular description of the invention, briefly summarized above, may be had by reference to embodiments. The accompanying drawings relate to embodiments of the invention and are described in the following: FIGS. 1A to ID show medical devices including stents as support structures and sensors according to embodiments described herein;
FIG. 2 shows a medical device including a stent assembly as a support structure and sensors according to embodiments described herein;
FIGS. 3A to 3C illustrate the monitoring of restenosis with medical devices according to embodiments described herein and with methods according to embodiments described herein; FIG. 4 illustrates a system including a stent, a sensor, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein;
FIGS. 5 and 6 illustrate yet further systems including support structures, at least one sensor, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein;
FIGS. 7 A and 7B illustrate rings that can be used to form support structures for embodiments described herein; FIGS. 8A to 8F illustrate sensors mounted to a ring for use in embodiments described herein; FIG. 9 shows a medical device including a support structure and sensors according to embodiments described herein;
FIGS. 10A to IOC illustrate the monitoring of restenosis with medical devices according to embodiments described herein and with methods according to embodiments described herein; FIG. 11 illustrate a flow chart for explain the benefits for treatment of e.g. restenosis and further deployment of angioplasty with medical devices according to embodiments described herein and with methods according to embodiments described herein;
FIGS. 12A and 12B illustrate systems including a support structure, sensors, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein; and
FIGS. 13A and 13B illustrate yet further systems including support structures, at least one sensor, a remote device for reading sensor values, and a computer system for monitoring a health condition, e.g. restenosis, according to embodiments described herein.
DETAILED DESCRIPTION OF EMBODIMENTS
[0015] Reference will now be made in detail to the various embodiments of the invention, one or more examples of which are illustrated in the figures. Within the following description of the drawings, the same reference numbers refer to same components. Generally, only the differences with respect to individual embodiments are described. Each example is provided by way of explanation of the invention and is not meant as a limitation of the invention. Further, features illustrated or described as part of one embodiment can be used on or in conjunction with other embodiments to yield yet a further embodiment. It is intended that the description includes such modifications and variations.
[0016] According to embodiments described herein, an intelligent implantable health sensing system is provided. The health sensing system can thereby, include one chip such as a RFID chip, or typically two or multiple RFID chips within support structure's length, e.g. stent's length, to measure and record spatially relative pressure differences. The one or more RFID chips may be integrated with a sensor. Measuring pressure differences helps to monitor any abnormality (restenosis, hemorrhage) systematically for early detection of restenosis and/or failure of a stent. Further, development of disease- and patient-specific cardiac models for early detection of myocardial infarction can be based upon embodiments described herein. [0017] According to yet further embodiments, which can be combined with other embodiments described herein, at least one of the two or more sensors is mounted to the support structure adjacent to the distal end, and wherein the another one of the two or more sensors is mounted to the support structure adjacent to the proximal end. The sensors can be employed as radiofrequency coils in magnetic resonance (MR) imaging systems. The sensors and/or chips, which may be further integrated with further structures can be used as MRI coupling coils (passive coupling through a LC circuit tuned to the MRI lamor frequency) for intravascular imaging. This can provide imaging information about a stenosis grade and also about the structure of the plaque. [0018] The health sensing system is supported with a user-interaction device, e.g. a remote device. According to typical embodiments, which can be combined with other embodiments described herein, the user-interaction device can be a computer or a mobile device, e.g. a smartphone and can optionally, be provided with back-end architecture for secure communication and recording of data and online/offline disease-, patient- , or patient-flow- modeling.
[0019] Embodiments described herein can provide a device in which senses the progression of restenosis and/or hemorrhage within the implanted stent upon user's request and sends this information to an external near-body device (e.g. a smartphone). The data can, for example, then transferred to a centralized database for online processing and decision-making. According to some embodiments, which can be combined with other embodiments described herein, two or multiple chips (sensors) are designed along with a stent to collect pressure indices and/or temperature indices, flow rate indices, and/or possible biomarkers.
[0020] According to some embodiments, two (or multiple) pressure sensors are designed on stent or another support structure and the pressure indices will be fetched through an external near-body device, such as a remote device including a reading device. The data is transferred to a centralized data station for online analysis and eventually a report is created. In case of life threatening situation, an alarm can be sent to an expert.
[0021] According to typical embodiments, at least two adjacent to at proximal and distal points of a stent are provided, which are configured to monitor the relative pressures difference between the two sensors. Multiple chips can also be designed within a stent another or support structure and therefore spatially relative pressures will be measured and recorded for any abnormality identification.
[0022] According to some embodiments, which can be combined with other embodiments described herein, the devices and systems employ multiple sensors and measure the spatially relative pressure differences. Accordingly, variations in blood pressure due to stress or other abnormal health conditions can be compensated as the pressure difference at two predetermined positions, e.g. a proximal and distal end of a stent or a graft, is measured. Hence, embodiments facilitate detection of any abnormality within the stent in a simpler and more reliable manner compared to measurements with one sensor. Furthermore, in case one of the sensing devices would be malfunctioning due to a failure or due to extensive plaque covers on one of the sensing devices (chips), the other(s) sensing devices can continue providing information.
[0023] According to some embodiments, which can be combined with other embodiments described herein, the devices and systems employ multiple sensors and/or chips and measure the spatially relative pressure differences. Accordingly, the first measurements right after implantation can be deploy for data calibration. The data calibration includes measured relative pressure differences, which are served to assess disease severity under different psychological and physical conditions (e.g. rest, exercise, stress, etc.). For example, saturation of sensors can be an indicative for abrupt or gradual changes in disease severity. [0024] FIG. 1A illustrates a first embodiment of a medical device (100). FIG. 1A shows two sensors 110 mounted in vicinity of opposing ends of a support structure, e.g. a stent 20. The stent with the sensors attached thereto can be implanted in a blood vessel according to general usage of a stent for vascular disease. The sensors 110 are provided in longitudinal direction of a blood vessel and can, thus, be configured to provide a pressure value at a first longitudinal position and a second longitudinal position. According to embodiments described herein, the pressure difference can be sensed to monitor the health condition as described in more detail with respect to FIGS. 3 A to 3C.
[0025] According to typical embodiments, which can be combined with other embodiments described herein, the sensors 110 can be radio-frequency chips or integrated with radio- frequency chips, similar to RFID chips. Thereby, the sensors are powered by an external RF source, e.g. in the GHz range, such as 2 GHz to 100 GHz. On receiving energy by the external source, the sensors 110 provide pressure values of the actual pressure at the sensor. The pressure values are transmitted with a wireless connection to an external reading device. According to a typical example, the external RF source and the reading device can be integrated in one remote device for powering and reading the sensors. [0026] During operation such a remote device or the respective RF source and the reading device can be held next the patient's body part, in which the stent 20 with the sensor 110 is implanted for a predetermined period of time. The pressure values can e.g. be read during a time period ranging from 5 seconds to 5 minutes, e.g. 2 min. A few heart cycles can be measured in that time period. Thereby, statistically improved pressure values, e.g. average values or values optimized by other statistic models (e.g. variance correlation) and signal processing technique (e.g. spectral analysis) can be obtained. The limitation to a predetermined time period further has the benefit that possible heat generation due to energy consumption of the chip can be limited to a time span, which is harmless to the tissue of the blood vessel in which the stent is implanted.
[0027] As shown in FIG. 1A, two sensors can be provided adjacent to the ends of the support structure, e.g. stent 20. According to yet further embodiments, which can be combined with other embodiments described herein, more than two sensors 110 can be provided. As shown in FIG. IB for example four sensors 110 can be provided. However, any other suitable number of sensors 110 can be provided, wherein the number may depend on the longitudinal length of the stent 20. For embodiments, including two sensors 110 or even one sensor 110, the data transmitted from the sensors to the reading device can consist of the pressure values as a function of time, yet, more information may be included as described in more detail below. The reduction to a pair (sensor 1 and sensor 2) of pressure values or a single pressure values (one sensor) is possible, as only one value is provided or only a pressure difference is considered. For embodiments including more than two sensors 110, typically a sensor ID is further transmitted by each of the sensors. Thereby, it is possible to calculate pressure difference between specific ones of the sensors such that the pressure differences, which can be calculated from the plurality of timely corresponding pressure values do not get confused and can be correlated to a specific pair of sensors 110. [0028] As shown in FIGS. 1A and IB, the sensors 110 are provided at the outside of the stent 20. Yet, as the stent 20 has a mesh forming the stent, the sensors are exposed to the blood in the vasculature. FIGS. 1C and ID show corresponding embodiments of medical devices 100, where the sensors 110 are provide at the inside of the stent. This arrangement is, for example, used when a membrane is used with the stent or a graft having a membrane is used as a support structure. Thereby, the blood pressure within the vasculature, i.e. for example not in the sac of an aneurysm, is measured by the sensors 110 towards the inside side of the membrane.
[0029] As described above, the support structure, which is configured to be implanted in a human or animal body together with the sensors 110, can be provided by a stent or a graft. However, according to yet further embodiments, which can be combined with other embodiments described herein, the support structure can also be provided by a stent arrangement comprising two or more stents. FIG. 2 shows an example of a medical device with a support structure including three stents 20. Thereby, three stents 20 are shown as implanted in a blood vessel along a longitudinal direction of the vessel 10. The medical device includes two sensors 110, which are arranged adjacent a distal and proximal end of the stent arrangement. However, according to yet further embodiments, the sensors can have any predetermined longitudinal position along the support structure, e.g. the stent assembly, which provides a sufficient distance between a first sensor and a second sensor to sense a pressure difference indicative of the health condition to be monitored. Thereby, according to typical embodiments described herein, which can be combined with other embodiments described herein, the predetermined position is defined merely by a longitudinal position, i.e. a rotation along the longitudinal axis is not considered and measurement results are irrespective thereof. This can, for example, be provided by the fact that pressure differences are considered.
[0030] FIGS. 3A to 3C show a medical device 100 provided in a blood vessel 10, wherein restenosis indicated by areas 30A, 30B and 30C increasingly occurs from 30A to 30B and further to 30C. Thereby, FIG. 3A shows a healthy condition or a condition which is almost healthy when considering a stent implantation. FIG. 3B shows a growing restenosis. FIG. 3C shows a critical restenosis. As shown by the curves 310, 312 and 314, the growing restenosis results in a reduced pressure value at the respective sensor 110 of the medical device 100. As indicated by arrow 320, a pressure difference between the sensor values corresponding to a time t is determined and the health condition, e.g.. the extent to which restenosis occurs is determined by the pressure difference indicated by arrow 320. According to different embodiments, which can be combined with other embodiments described herein, the pressure difference can be considered at 60% to 90 %, e.g. 80% of the peak value (100%), either of the lower pressure peak as shown in the figures or of the higher pressure peak. The pressure functions shown in the graphs of FIGS. 3A to 3C basically correspond to the pressure values during one heartbeat. A measurement with a remote reading device is typically conducted for a longer time interval, e.g. 10 sec to 3 min, such that a more accurate measurement can be conducted as described above. Accordingly to typical examples, which can yield further embodiments, with the embodiments disclosed herein, the data rate transmitted from a sensor to the remote device can range from 20 to 100 Kbit per second, for example 40-50 Kbit/s. According to some embodiments, which can be combined with other embodiments described herein, the restenosis can be detected within the support structure, e.g. a stent and/or between the at least two sensors. Alternatively, it is possible to use the plurality of pressure values also to sense restenosis or similar abnormality before or after the stent in the vicinity thereof. -
[0031] FIG. 4 illustrates yet further embodiments described herein. A medical device for implantation 400 includes a support structure, e.g. a stent, a stent arrangement, a graft, or the like, and at least on sensor 10 mounted to the support structure. The sensors according to embodiments described herein typically have not internal power supply. The sensor 1 10 is configured to sense at least the pressure inside a vascular. Optionally, further biological indices of interest can be included like one or more of a temperature, a flow rate or detection of biomarkers can be conducted as well. Thereby, for those embodiments having two or more corresponding sensors, value differences are considered at least for the pressure, the temperature and or the flow rate.
[0032] According to typical embodiments described herein, the sensor can be provided by a MEMS (micro-electro-mechanical system). Thereby, a chip can be provided with a pressure sensor, a wireless power supply (see, e.g. RFID), a microelectronics and an antenna for transmitting the pressure values and/or further parameter values, or even a sensor ID to an external receiver or reading device. Accordingly, the sensor can include an HF frontend module for transmitting the sensed values as a function of time. The entire electronic can be provided on the chip. The sensor or chip further includes the measurement device or mechanical device, e.g. the pressure gauge, a wireless power supply, wherein the energy is transmitted by RF radiation, e.g. in the GHz range to the sensor, and optionally also a control unit and/or evaluation unit. According to alternatives a control unit and/or evaluation unit can also be provided in a remote reading device receiving the data.
I I [0033] As shown in FIG. 4, RF radiation 415 is emitted by a remote device 410. The RF radiation is used to energize the sensor 110, which in turn transmits data of measurement values and optionally other information as a wireless signal to the remote device 410 as indicated by signal 416. The remote device 410 includes the transmitter for the RF energy as well as a reading device for reading the data transmitted from the sensor 110. Alternatively, the remote RF transmitted and the reading device can also be separated. The remote device 410 is connected to a computer system 420 via connection 411. The computer system can be a personal computer, a portable computer, a server structure, a cloud structure or combinations thereof. Typically, utilizing a back-end portal structure with encrypted communication techniques allows for further data processing. Thereby, historical information and current information can be shared and compared and additional information like medication or the like can be considered in a model calculation. Those results can be shared with the user of the remote device 410 and/or a medical scientist (doctor). If critical or even emergency conditions are found, the patient, typically the user of the remote device, and/or the doctor can be informed or an alert could be generated.
[0034] FIG. 5 shows an embodiment where a medical device 100 having two sensors 110 is provided in a blood vessel 10. The details for power supply and data transfer from the remote device 410 to the sensors 110, which have been described above with respect to FIG. 4 can also be incorporated in the embodiments described with respect to FIG. 5 to yield yet further embodiments. The remote device 410 is connected to a computer system 420, e.g. a laptop, which is connected to the World Wide Web and server structure, e.g. in the form of a cloud solution 422. As indicated by the arrows in FIG. 5, the server structure can communicate back to the user. The cloud solution facilitates sharing of information, e.g. with a medical expert.
[0035] FIG. 6 illustrates yet a further embodiment, where the remote device having the RF transmitter for energy transfer and the reading device for data receipt incorporated in a mobile device, such as a smart phone or the like, which can directly communicate with servers provided in a network. Modifications and implementations described above with respect to sensor arrangement, measurement methods and sensor chip design and wireless communication techniques can likewise be applied for solutions shown in FIGS. 5 and 6. [0036] As described above, a support structure, which is configured to be implanted in a human or animal body together with the sensors 110, is provided. Thereby, as already shown in FIG: 2, the support structure can have two or more elements. According to some typical implementations, the sensors can be provided on different ones of the two or more elements.
[0037] According to some embodiments, which can be combined with other embodiments described herein, the support structure can include: a stent, a stent arrangement, a graft, a graft arrangement, two or more rings, or two or more plates, e.g. plate patches, or other elements or medical devices that can be inserted in a vessel. Thereby, according to some additional or alternative implementations, a ring can be provided as a short stent, i.e. a stent with a length in axial direction of 5 mm or below. Unlike stents, the rings are not employed or configured to push away plaques toward arterial walls and open up the site of occlusion but employed through balloon angioplasty by placing them at distal or proximal ends of an inflating balloon. The primary role of the rings is to facilitate online monitoring of disease progression through presented embodiments. The rings and support structures can according to some embodiments, which can be combined with other embodiments described herein, be self- expandable. According to typical embodiments, which can be combined with other embodiments described herein, the ring can be round, oval or any other shape configured to be arranged in a vessel of an animal or human.
[0038] According to yet further embodiments, the sensors can have any predetermined longitudinal position along the support structure, e.g. the stent arrangement or ring arrangement, which provides a sufficient distance between a first sensor and a second sensor to sense a pressure difference indicative of the health condition to be monitored. Thereby, according to typical embodiments described herein, which can be combined with other embodiments described herein, the predetermined position is defined merely by a longitudinal position, i.e. a rotation along the longitudinal axis is not considered and measurement results are irrespective thereof. This can, for example, be provided by the fact that pressure differences are considered.
[0039] FIGS. 7A and 7B show pictures of rings 700A and 700B respectively. As can be seen, the rings 700A and 700B have a similar structure as a stent. However they are comparably short in axial direction. According to one definition, a ring could have a dimension in axial direction, which is shorted than the diameter of the ring. [0040] FIGS. 8A to 8F show different variations of providing sensors 110 provided at a ring 820. FIGS. 8A to 8C show embodiments, for which one sensor 110 is attached or mounted to the ring 820. Thereby, according to different embodiments, the sensor can be provided to be essentially radially outward of the ring 820 (see FIG. (A), essentially radially inward of the ring 820 (see FIG. 8C), or on the ring or within the ring. For example, the ring can be closed by the sensor, i.e. the ring is attached on two sides of the sensors (see FIG. 8B). For embodiments as illustrated by FIG. 8B, the sensor has essentially the same radial position as the ring.
[0041] According to yet further embodiments, as illustrated in FIGS. 8D to 8F, two sensors 110 can be provided on one ring 820. Similar to the description with respect to FIGS. 8A to 8C, the sensors 110 can be provide at different radial positions with respect to the ring. That is, the sensors 110 can be provided essentially radially outward (see FIG. 8D), essentially radially inward (see FIG. 8F, or essentially at a similar radial position as the ring (see FIG. 8E). It is to be understood that for two or more sensors, also different positions with respect to the ring 820 can be provided for one ring, i.e. one sensor is essentially radially inward and one sensor is essentially radially outward, etc. [0042] Further, according to yet further embodiments, also 3, 4 or 5 sensors can be provided at one ring. Providing two or more sensors at the ring can increase the measurement accuracy because more than one signal can be obtained at one axial position, i.e. the axial position of the ring having the two or more sensors. Further, redundancy is provided in the event one of the two or more sensors fails to provide reliable signals, e.g. because of a failure or by coverage of plaque. In case one of the sensing devices would be malfunctioning due to a failure or due to extensive plaque covers on one of the sensing devices (chips), the other(s) sensing devices can continue providing information.
[0043] According to some embodiments, which can be combined with other embodiments described herein, two rings 820, each with at least one sensor 110, forms a medical device 1200, as e.g. shown in FIG. 9. Thereby, the support structure of the medical device can be provided by two or more rings. The two rings 820, wherein each ring 820 has two sensors 110 or sensing devices mounted thereon are configured to be implanted in a blood vessel along a longitudinal direction or axis 110 of the vessel 10. It is to be understood that even though the axis 110 is shown as a straight line in FIG. 9, the axis 110 is defined as following a potential curvature of the vessel 10. Thereby, the two rings 820 each having at least one sensor 110 form the medical device 1200 according to embodiments described herein. The rings can be provide at predetermined positions along the axis 11 or at a predetermined distance along the axis 11 in order to be able to monitor the health condition with respect to plaque coverage of vessel 10.
[0044] FIGS. 10A to IOC show a medical device 1200 provided in a blood vessel 10, wherein stenosis or restenosis indicated by areas 30A, 30B and 30C increasingly occurs from 30A to 30B and further to 30C. Thereby, FIG. 10A shows a healthy condition or a condition which is almost healthy when considering a surgery. FIG. 10B shows a growing restenosis. FIG. IOC shows a critical restenosis. As shown by the pressure levels 510, 520A, 520B and 520C, the growing restenosis results in a reduced pressure value at the respective sensor of the medical device 1200. As indicated by arrow 550, a pressure difference between the sensor values is determined and the health condition, e.g. the extent to which restenosis occurs is determined by the pressure difference indicated by arrow 550. According to different embodiments, which can be combined with other embodiments described herein, the pressure difference can be considered to have a threshold at 50% to 90 %, e.g. 80% of the higher pressure. Accordingly, if the pressure difference exceeds a certain value or if the lower value 520A,B,C drops below a certain percentage of the higher value 510, a critical conditions is detected. According to some embodiments, which can be combined with other embodiments described herein, the restenosis can be detected within the support structure, e.g. a stent and/or between the at least two sensors. Alternatively, it is possible to use the plurality of pressure values also to sense restenosis or similar abnormality before or after the stent in the vicinity thereof.
[0045] FIG. 11 shows a flow chart illustrating the benefits in treatment of atherosclerotic disease, stenotic disease, other vascular disease, e.g. stenosis or restenosis, with and according to embodiments described herein, particularly when two or more rings 820 as shown in FIGS. 7A to IOC and 12A to 13B are utilized. After diagnosing atherosclerosis (see box 112) commonly a stent implantation (see box 116) could be used as a treatment. This decision is indicated by dashed arrows 113 A. Thereby, the stent pushed away the plaque in the vessel to increase the open diameter of the vessel. Unless atherosclerosis could be stopped, double stenting as indicated by arrow 113B could be used in some cases. However, typically after stenting a bypass surgery (see box 118) was typically the next treatment as indicated by arrow 113C. The stenting could prevent or postpone a bypass surgery for some time. According to some embodiments described herein, during stent implantation a medical device according to embodiments described herein can be implanted in order to monitor the status of atherosclerosis , stenotic disease, other vascular disease, e.g. stenosis or restenosis, and improve the diagnosis.
[0046] Particularly for embodiment, wherein two or more rings are used as a support structure for the sensors and thereby forming a medical device, additional benefits can be obtained. In a first treatment a balloon angioplasty (see box 114) can be provided. A balloon pushes away the plaque in a vessel. During balloon angioplasty to rings, each with at least one pressure sensor can be implanted. Thereby, atherosclerosis or other stenotic or vascular disease can be treated and at the same time a valuable monitor ability can be provided. Accordingly, a stent implantation can be postponed, whereby the risk during postponing the stent implantation can be determined by the monitoring capability of the medical devices according to some embodiments described herein. Such a surgery could be repeated, e.g. after one or two years as indicated by arrow 115.
[0047] In the event atherosclerosis or other stenotic or vascular disease could not be stopped, a stent implantation (box 116) could be postponed with a good risk management. Thereby, several years (e.g. 1 to 3) can be gained before a stent implantation and consequently also before bypass surgery (see box 118) as a further step after stent implantation. In addition for stent implantation and/or for bypass surgery, a monitoring capability can be provided by embodiments described herein. This is indicated by arrows 117 and 119. It is to be understood that the monitoring can be added in the same surgery as the stent implantation or the bypass surgery even though arrows 117 and 119 point back to the balloon angioplasty.
[0048] FIGS. 12A and 12B illustrate yet further embodiments described herein. A medical device for implantation 1200 includes a support structure, which can be provided by two rings 820 in the form of a short stents or two other rings. At least two sensors 110 are mounted to the support structure, wherein an axial distance is provided for the two sensors. The sensors according to embodiments described herein typically have not internal power supply. The sensors 110 are configured to sense at least the pressure inside a vascular. Optionally, one or more of a temperature, a flow rate or detection of biomarkers can be conducted as well. Thereby, for those embodiments having two or more corresponding sensors, value differences are considered at least for the pressure, the temperature and/or the flow rate. [0049] According to typical embodiments described herein, the sensors can be provided by a MEMS (micro-electro-mechanical system). Thereby, a chip can be provided with a pressure sensor, a wireless power supply (see, e.g. RFID), a microelectronics and an antenna for transmitting the pressure values and/or further parameter values, or even a sensor ID to an external receiver or reading device. Accordingly, the sensor can include an HF frontend module for transmitting the sensed values as a function of time. The entire electronic can be provided on the chip. The sensor or chip further includes the measurement device or mechanical device, e.g. the pressure gauge, a wireless power supply, wherein the energy is transmitted by RF radiation, e.g. in the GHz range to the sensor, and optionally also a control unit and/or evaluation unit. According to alternatives a control unit and/or evaluation unit can also be provided in a remote reading device receiving the data.
[0050] As shown in FIGS. 12A and 12B, RF radiation 415 is emitted by a remote device 410. The RF radiation is used to energize the sensors 110, which in turn transmit data of measurement values and optionally other information as a wireless signal to the remote device 410 as indicated by signals 416. The remote device 410 includes the transmitter for the RF energy as well as a reading device for reading the data transmitted from the sensors 110. Alternatively, the remote RF transmitted and the reading device can also be separated. The remote device 410 is connected to a computer system 420 via connection 411. The computer system can be a personal computer, a portable computer, a server structure, a cloud structure or combinations thereof. Typically, utilizing a back-end portal structure with encrypted communication techniques allows for further data processing. Thereby, historical information and current information can be shared and compared and additional information like medication or the like can be considered in a model calculation. Those results can be shared with the user of the remote device 410 and/or a medical scientist (doctor). If critical or even emergency conditions are found, the patient, typically the user of the remote device, and/or the doctor can be informed or an alert could be generated.
[0051] FIG. 13A shows an embodiment where a medical device 1200 having two sensor 110 is provided in a blood vessel 10. According to typical embodiments, which can be combined with other embodiments described herein, the support structure of the medical device can include two short stents or two rings. The details for power supply and data transfer from the remote device 410 to the sensors 110, which have been described above with respect to FIGS. 12A and 12B can also be incorporated in the embodiments described with respect to FIG. 13A to yield yet further embodiments. The remote device 410 is connected to a computer system 420, e.g. a laptop, which is connected to the World Wide Web and/or a server structure, e.g. in the form of a cloud solution 422. As indicated by the arrows in FIG. 13 A, the server structure can communicate back to the user. The cloud solution facilitates sharing of information, e.g. with a medical expert.
[0052] FIG. 13B illustrates yet a further embodiment, where the remote device having the RF transmitter for energy transfer and the reading device for data receipt incorporated in a mobile device, such as a smart phone or the like, which can directly communicate with servers provided in a network. Modifications and implementations described above with respect to sensor arrangement, measurement methods and sensor chip design and wireless communication techniques can likewise be applied for solutions shown in FIGS. 13A and 13B.
[0053] Accordingly, embodiments described herein serve for health monitoring of atherosclerotic disease, stenotic disease, other vascular disease, e.g. stenosis or restenosis after stent implantation, stent breakage, or the like. Embodiments described herein, can yield yet further embodiments, when utilized as methods where a continuous monitoring is provided. E.g. remote device can be placed external to a human or animal body in the vicinity of or directed towards the implanted sensor(s) on a regular basis, e.g. daily or weekly or the like and the data can be transferred and evaluated accordingly. Thereby, growing restenosis can be sensed at an early stage.
[0054] The sensor or sensors provided use RF energizing techniques such as or similar to RFID chips. Thereby, the implanted sensor or sensors can be miniaturized sufficiently to also be provided in cardiovascular vessels, where stent length of 1.0 mm to 20 mm or other places at the human or animal body where stent length of 2 cm to 20 cm are utilized. According to yet further additional or alternative modifications, the implanted sensor or sensors can be miniaturized sufficiently to also be provided in vessels, where stent diameters are from 0.5 mm to 20 mm, e.g. from 1 mm to 15 mm, such as from 1 mm to 10 mm . Accordingly, the sensor can be miniaturized to a degree beyond previously known sensor for implantation. According to yet further embodiments, which can be combined with other embodiments described herein, two or more sensors are provided, wherein a pressure difference of at least two sensors is sensed. This simplifies and improves sensing of the health condition. Further, rotational positioning can be disregarded. According to yet further embodiments, which can be combined with other embodiments described herein, the support structure can be the stent or two or more stents, which are implanted for curing the vascular or cardiovascular disease. Accordingly, the health monitoring device is in place at least after the surgery for treating the original disease. Thereby, according to optional modifications, a calibration of the freshly implanted stent, e.g. an initial pressure difference can be provided.
[0055] According to yet further embodiments, which can be combined with other embodiments described herein, the sensor can be provided in a chip, e.g. as MEMS and/or as silicon based integrated HF circuits and particularly, with wireless broadband communication. Typically, the sensor can be a SoC (System on Chip), wherein sterile packaging can be provided as known in the art.
[0056] Data transmission from the sensor occurs initially to a remote device, e.g. a smart phone or another device, and is typically provided to a backend server portal, e.g. in the form of a server cloud solution. The server solution can allow, e.g. with encrypted communication such as AES, reference to a plurality of sensor information, historical data, medication information, expert information from a doctor and other information of interest for a user. The information can be graphically shown to the user for ease of understanding. Further, a cloud solution allows access from different location and also access of different persons, e.g. doctors or emergency physicians.
[0057] According to yet further embodiments, which can be combined with other embodiments described herein, a sensing system for quasi-continuous sensing as described herein and methods of monitoring, can further include a test phase with a medication model A, where a plurality of measurement cycles are conducted for a time period of days or weeks and a test phase with a medication model B, where another plurality of measurement cycles are conducted for a period of days or weeks, such that an individual medication for each patient can be developed efficiently.
While the foregoing is directed to embodiments of the invention, other and further embodiments of the invention may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow.

Claims

1. A device configured for monitoring one or more health conditions, particularly restenosis, comprising: two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided in a vessel, wherein each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft; a support structure for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is closer to the distal end than another one of the two or more sensors; and an a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values.
2. The device according to claim 1, wherein the at least one of the two or more sensors is mounted to the support structure adjacent to the distal end, and wherein the another one of the two or more sensors is mounted to the support structure adjacent to the proximal end.
3. A device configured for monitoring one or more health conditions, particularly restenosis, comprising: one or more sensors configured to be implanted in a vascular, wherein the one or more sensors are configured to sense at least pressure values; a support structure for supporting the one or more sensors; an a remote device for wirelessly providing energy to the one or more sensors and for reading the pressure values.
4 The device according to any of claims 1 to 3, further comprising: a wireless power supply provided by one or more RFID chip, a microelectronics and an antenna for transmitting, particularly wirelessly, the pressure values, particularly wherein the one or more RFID chips are integrated with the sensors.
5. The device according to claim 4, wherein at least one of the sensors is mounted to the support structure adjacent to the distal end, and wherein the another one of the sensors is mounted to the support structure adjacent to the proximal end, wherein the two or more sensors and the RFID chips are employed as radiofrequency coils in magnetic resonance (MR) imaging systems, particularly wherein the sensors and the RFID chips are configured as MRI coupling coil for intravascular imaging.
6. The device according to any of claims 1 to 5, wherein the sensors are provided in a chip, particularly as MEMS and/or as silicon based integrated HF circuits, and more particularly with wireless broadband communication.
7. The device according to any of claims 4 to 6, wherein the sensors and at least one of the RFID chip and the chip are integrated with each other.
8. The device according to any of claims 1 to 7, wherein the support structure is selected from the group consisting of: one stent, a stent arrangement comprising two or more stents, two or more rings, to or more plate patches, a graft and any of their combinations thereof.
9. The device according to any of claims 1 to 2 or 4 to 8, further comprising: a reading device configured for wireless communication with the two or more sensors.
10. The device according to claim 3, wherein the remote device includes a reading device according to claim 9.
11. The device according to any of claims 9 to 10, wherein the reading device further comprises an RF emitter for providing energy to the sensors.
12. The device according to any of claims 9 to 11, wherein the reading device comprises a port for wired or wireless communication with a computer system.
13. The device according to clam 12, wherein the computer system is a system selected from the group consisting of: a personal computer, a portable computer, a smartphone, a server, a cloud computer system, and combinations thereof.
14. The device according to any of claims 9 to 13, wherein the reading device is integrated in a mobile device.
15. A method of monitoring a health condition, particularly restenosis, comprising: wirelessly energizing at least one sensor, which senses at least vascular pressure values, with a remote device; reading at least the pressure values for a predetermined time period via a wireless data transfer from the at least one sensor; communicating the pressure values to a computer system; receiving information related to the health condition from the computer system.
16. The method according to claim 15, wherein the energizing includes emitting of RF radiation.
17. The method according to any of claims 15 to 16, wherein the computer system is a system selected from the group consisting of: a personal computer, a portable computer, a smartphone, a server, a cloud computer system, and combinations thereof.
18. The method according to any of claims 15 to 17, wherein the at least one sensor is at least two sensors and the difference of respective pressure values from each of the at least two sensors is evaluated in the computer system.
19. The method according to any of claims 15 to 18, further comprising:
calibrating the at least one sensor within a second predetermined time period after a support structure implantation.
20. A device configured for monitoring one or more health conditions, particularly restenosis, comprising: two or more sensors configured to be implanted for exposure to blood within a vessel or to blood within a graft provided in a vessel, wherein each of the two or more sensors is configured to sense at least the pressure in the vessel or the graft; a support structure having two or more rings configured to be implanted in a vessel and for supporting the two or more sensors, wherein the support structure has a distal end and a proximal end, wherein at least one of the two or more sensors is arranged at a first ring of the two or more rings, which is closer to the distal end than a second ring of the two or more rings, wherein at least another sensor of the two or more sensors is attached to the second ring; and a remote device for wirelessly providing energy to the one or more sensors and RFID chips and for reading the pressure values; and a reading device configured for wireless communication with the two or more sensors and RFID chips and comprising a port for wired or wireless communication with a computer system, wherein the computer system is a system selected from the group consisting of: a personal computer, a portable computer, a smartphone, a server, a cloud computer system, and combinations thereof.
PCT/EP2013/065322 2012-07-20 2013-07-19 Intelligent implanted health sensing device and assembly WO2014013062A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/415,232 US20150164372A1 (en) 2012-07-20 2013-07-19 Intelligent implanted health sensing device and assembly
CN201380038579.4A CN104703532A (en) 2012-07-20 2013-07-19 Intelligent implanted health sensing device and assembly
EP13739235.3A EP2941179A1 (en) 2012-07-20 2013-07-19 Intelligent implanted health sensing device and assembly

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12177301.4 2012-07-20
EP12177301 2012-07-20

Publications (1)

Publication Number Publication Date
WO2014013062A1 true WO2014013062A1 (en) 2014-01-23

Family

ID=48803568

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/065322 WO2014013062A1 (en) 2012-07-20 2013-07-19 Intelligent implanted health sensing device and assembly

Country Status (4)

Country Link
US (1) US20150164372A1 (en)
EP (1) EP2941179A1 (en)
CN (1) CN104703532A (en)
WO (1) WO2014013062A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3131460A4 (en) * 2014-04-18 2017-12-13 Vivonics, Inc. Flow rate sensor system and method for non-invasively measuring the flow rate of a bodily fluid
WO2023131696A1 (en) * 2022-01-10 2023-07-13 Biotronik Se & Co. Kg Automatic control of a therapy efficiency of a shunt surgery (of patients with liver cirrhosis)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9427305B2 (en) 2013-01-24 2016-08-30 GraftWorx, LLC Method and apparatus for measuring flow through a lumen
US9215075B1 (en) 2013-03-15 2015-12-15 Poltorak Technologies Llc System and method for secure relayed communications from an implantable medical device
US20150320357A1 (en) * 2014-02-20 2015-11-12 GraftWorx, LLC Methods for assessing fluid flow through a conduit
CN106361303A (en) * 2016-08-30 2017-02-01 福州瑞芯微电子股份有限公司 Blood vessel detection integrated chip and implementation method thereof
WO2018049412A1 (en) 2016-09-12 2018-03-15 Graftworx, Inc. Wearable device with multimodal diagnostics
CN107137161B (en) * 2017-06-21 2018-02-13 张天华 A kind of monitoring system of dissection of aorta support containing chip and the support
US20190122757A1 (en) * 2017-10-22 2019-04-25 Rui Lin Method and device for software-defined therapy
IT201800003300A1 (en) * 2018-03-06 2019-09-06 Walter Rossetti MEDICAL DEVICE FOR MEASURING THE BLOOD PRESSURE OF A PATIENT
US11083604B2 (en) 2019-01-18 2021-08-10 Lawrence Livermore National Security, Llc Preventing stent failure using adaptive shear responsive endovascular implant
CN113208787B (en) * 2021-05-10 2022-09-27 首都医科大学附属北京天坛医院 Support component device for non-invasive monitoring of restenosis in coronary stent
US20220399123A1 (en) 2021-06-14 2022-12-15 Preh Holding, Llc Connected body surface care module
WO2023186590A1 (en) * 2022-03-31 2023-10-05 Koninklijke Philips N.V. Flow sensing vascular implant

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US6331163B1 (en) * 1998-01-08 2001-12-18 Microsense Cardiovascular Systems (1196) Ltd. Protective coating for bodily sensor
US20050080346A1 (en) * 2002-12-16 2005-04-14 The Regents Of The University Of Michigan Antenna stent device for wireless, intraluminal monitoring
US20100179449A1 (en) * 2009-01-12 2010-07-15 Purdue Research Foundation Miniature stent-based implantable wireless monitoring devices
US20100217136A1 (en) * 2003-11-04 2010-08-26 L & P 100 Limited Medical devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997031454A1 (en) * 1996-02-22 1997-08-28 Kvaser Consultant Ab Device in a system operating with can-protocol and in a control and/or supervision system
US6328699B1 (en) * 2000-01-11 2001-12-11 Cedars-Sinai Medical Center Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure
US20080208039A1 (en) * 2007-02-28 2008-08-28 Wisconsin Alumni Research Foundation System and method of performing therapeutic endovascular interventions
US20140081154A1 (en) * 2011-05-17 2014-03-20 Landy Toth Devices, systems, and methods for assessing implants, organs, transplants, tissues, synthetic constructs, vascular grafts, and the like

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US6331163B1 (en) * 1998-01-08 2001-12-18 Microsense Cardiovascular Systems (1196) Ltd. Protective coating for bodily sensor
US20050080346A1 (en) * 2002-12-16 2005-04-14 The Regents Of The University Of Michigan Antenna stent device for wireless, intraluminal monitoring
US20100217136A1 (en) * 2003-11-04 2010-08-26 L & P 100 Limited Medical devices
US20100179449A1 (en) * 2009-01-12 2010-07-15 Purdue Research Foundation Miniature stent-based implantable wireless monitoring devices

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FOX NEWS REPORT, 9 October 2008 (2008-10-09)
PENG CONG ET AL: "Wireless Batteryless Implantable Blood Pressure Monitoring Microsystem for Small Laboratory Animals", IEEE SENSORS JOURNAL, IEEE SERVICE CENTER, NEW YORK, NY, US, vol. 10, no. 2, 1 February 2010 (2010-02-01), pages 243 - 254, XP011286638, ISSN: 1530-437X, DOI: 10.1109/JSEN.2009.2030982 *
THE BOSTON GLOBE, 26 December 2004 (2004-12-26)
THE NEW YORK TIMES, 13 February 2007 (2007-02-13)
THE WALL STREET JOURNAL, 7 May 2007 (2007-05-07)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3131460A4 (en) * 2014-04-18 2017-12-13 Vivonics, Inc. Flow rate sensor system and method for non-invasively measuring the flow rate of a bodily fluid
WO2023131696A1 (en) * 2022-01-10 2023-07-13 Biotronik Se & Co. Kg Automatic control of a therapy efficiency of a shunt surgery (of patients with liver cirrhosis)

Also Published As

Publication number Publication date
EP2941179A1 (en) 2015-11-11
CN104703532A (en) 2015-06-10
US20150164372A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
US20150164372A1 (en) Intelligent implanted health sensing device and assembly
US11445978B2 (en) Stent graft monitoring assembly and method of use thereof
CN110384575B (en) Bracket monitoring assembly and use method thereof
US11911141B2 (en) Devices, systems and methods for using and monitoring tubes in body passageways
US20200268316A1 (en) Devices, systems and methods for using and monitoring heart valves
CN105050491B (en) For measuring the method and apparatus through the stream of tube chamber
US7044920B2 (en) Pressure monitoring system to prevent aneurismal sac rupture
Abraham et al. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure
RU2607340C2 (en) Dynamic surgical measurement of flow
US20220167922A1 (en) Providing medical devices with sensing functionality
JP2023546031A (en) Providing medical devices with sensing functions
US20230290497A1 (en) Implantable sensor device
RU2613086C2 (en) Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity
ES2393878B1 (en) ENDOFUGAS DETECTOR DEVICE FOR ENDOPROTESIS.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13739235

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2013739235

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 14415232

Country of ref document: US

Ref document number: 2013739235

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE